Recorded: 04 Jun 2001
Generally speaking, it was great! It’s a bit like if you go away on a camping trip with somebody and you go through some adversity together, there was tremendous bonding between the people here because we were all in this kind of hothouse atmosphere. You got to be very good friends with people very quickly. The friends I’ve made here, I still see them a lot. There’s always that very special—well, people like Ashley Dunn, and Keith Willison and Mike Botchan to some extent and Terri Grodzicker, a lot of people who were here, that you feel a special—[Bob] Tjian.
David Lane, immunologist, is the Director of the Cancer Research UK Transformation Research Group at the University of Dundee, Department of Surgery and Molecular Oncology at the Ninewells Hospital and Medical School in Dundee, Scotland. Lane founded the Department of Surgery and Oncology in the University’s Medical School with Alfred Cucheiri, one of the pioneers in minimal access ("keyhole") surgery. Currently on leave from the University of Dundee, he the Executive Director of the IMCB in Singapore. Lane is also the founder and Chairman of the Scientific Advisory Board of Cyclacel, a Dundee based biotechnology company now listed on the NASDAQ. Shortly after receiving his Ph.D., he was recruited by Joe Sambrook to work at Cold Spring Harbor Laboratory with the Tumor Virus Group in the 70’s, where he also completed one of his books on antibodies. In 2000, Lane was knighted by Queen Elizabeth of England for his many contributions to science. He is a Fellow of the Royal Society of London, the Academy of Medical Sciences, and the University College London.